Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationMyeloablative AgonistsStem CellsHematologic NeoplasmsBone Marrow TransplantationGraft SurvivalTransplantation ChimeraTreatment OutcomeBusulfanTissue DonorsGraft vs Leukemia EffectRemission InductionRecurrenceVidarabineCord Blood Stem Cell TransplantationImmunosuppressive AgentsLiver TransplantationHistocompatibility TestingHematopoietic Stem CellsWhole-Body IrradiationKidney TransplantationGraft vs Tumor EffectGraft RejectionCombined Modality TherapyMultiple MyelomaRetrospective StudiesLeukemiaLeukemia, Myeloid, AcuteMesenchymal Stem Cell TransplantationMelphalanLymphocyte TransfusionAcute DiseaseDisease-Free SurvivalSiblingsHistocompatibilitySurvival AnalysisTime FactorsSurvival RateSalvage TherapyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell TransplantationHeart TransplantationAntilymphocyte SerumCytomegalovirus InfectionsLymphocyte DepletionHematopoietic Stem Cell MobilizationHepatic Veno-Occlusive DiseaseEmbryonic Stem CellsCyclophosphamideChimerismAntineoplastic Combined Chemotherapy ProtocolsPrecursor Cell Lymphoblastic Leukemia-LymphomaMinor Histocompatibility AntigensNeoplasm, ResidualAdult Stem CellsImmunosuppressionVirus ActivationAntigens, CD34HLA AntigensFollow-Up StudiesHematologic DiseasesTransplantation ImmunologyCyclosporineT-LymphocytesPrognosisAnemia, AplasticCytomegalovirusLymphoma, Non-HodgkinCytarabineCell DifferentiationPluripotent Stem CellsGranulocyte Colony-Stimulating FactorTransplantation, IsogeneicHodgkin DiseaseLung TransplantationLeukemia, MyeloidNeural Stem CellsStem Cell NichePrimary MyelofibrosisAntineoplastic AgentsLiving DonorsInfectionMesenchymal Stromal CellsAntibodies, NeoplasmImmunocompromised HostLymphoproliferative DisordersEtoposideUnrelated DonorsBone Marrow CellsRoseolovirus InfectionsOrgan TransplantationLeukemia, Myeloid, Accelerated PhaseFlow Cytometry